前列腺癌
医学
雄激素受体
肿瘤科
内科学
转移
雄激素剥夺疗法
前列腺
雄激素
阉割
癌症
睾丸切除术
激素
作者
Karim Fizazi,Neal D. Shore,Teuvo L.J. Tammela,Albertas Ulys,Egils Vjaters,S. Polyakov,Mindaugas Jievaltas,Murilo Luz,B. Yа. Alekseev,Iris Kuss,Christian Kappeler,Amir Snapir,Toni Sarapohja,Matthew R. Smith
标识
DOI：10.1056/nejmoa1815671
摘要
Among men with nonmetastatic, castration-resistant prostate cancer, metastasis-free survival was significantly longer with darolutamide than with placebo. The incidence of adverse events was similar for darolutamide and placebo. (Funded by Bayer HealthCare and Orion Pharma; ARAMIS ClinicalTrials.gov number, NCT02200614.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
Nole
GingerF
LB
Criminology34
OK
Samuel
sci_fp
MchemG
Albert_Z
wueeee
斯文的初蝶
kakao
arniu2008
披着羊皮的狼
Copyright
做实验的猫
右子
YifanWang
皖公网安备34019202002308
